Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder
Summary
- Buprenorphine is associated with fewer adverse effects than methadone[Mattick 2008; Sung 2006] and is available in long-acting formulations[Johnson 1995; Sublocade 2018; Rosenthal 2016]
- Buprenorphine is available alone or in combination with naloxone
- Buprenorphine can be administered by any prescriber who obtains a license that begins with “X” (DEA); obtaining this license requires 8 hours of training (online or in-person) for an MD or DO and 24 hours of training for a nurse practitioner or physician assistant[ASAM 2015; DEA 2018]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content